{"title":"钠-葡萄糖协同转运蛋白2抑制剂在IgA肾病中的前景","authors":"S. Zandifar, Shokouh Shayanpour","doi":"10.34172/npj.2023.10606","DOIUrl":null,"url":null,"abstract":"Implication for health policy/practice/research/medical education: Sodium-glucose cotransporter-2 inhibitors is a promising treatment option for patients with diabetes-associated renal dysfunction.","PeriodicalId":16388,"journal":{"name":"Journal of Nephropharmacology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Promising role of sodium-glucose cotransporter-2 inhibitors in IgA nephropathy\",\"authors\":\"S. Zandifar, Shokouh Shayanpour\",\"doi\":\"10.34172/npj.2023.10606\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Implication for health policy/practice/research/medical education: Sodium-glucose cotransporter-2 inhibitors is a promising treatment option for patients with diabetes-associated renal dysfunction.\",\"PeriodicalId\":16388,\"journal\":{\"name\":\"Journal of Nephropharmacology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Nephropharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.34172/npj.2023.10606\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nephropharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/npj.2023.10606","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Promising role of sodium-glucose cotransporter-2 inhibitors in IgA nephropathy
Implication for health policy/practice/research/medical education: Sodium-glucose cotransporter-2 inhibitors is a promising treatment option for patients with diabetes-associated renal dysfunction.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
